Home > Boards > US Listed > Biotechs > Aquestive Therapeutics Inc (AQST)

Upcoming PDUFA 9/27/20

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DorseyE Member Profile
 
Followed By 8
Posts 2,118
Boards Moderated 0
Alias Born 08/09/03
160x600 placeholder
Aquestive Therapeutics to Host Investor & Analyst Virtual Epinephrine Drug Delivery R&D Event on March 25 at 9:00 a.m. ET GlobeNewswire Inc. - 3/5/2021 7:00:00 AM
Aquestive receives FDA feedback; to resubmit marketing application for Libervant Seeking Alpha - 2/25/2021 7:59:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2021 7:31:03 AM
Aquestive Therapeutics Reaffirms Near-Term NDA Resubmission for Libervant™ (diazepam) Buccal Film Following FDA Feedback GlobeNewswire Inc. - 2/25/2021 7:30:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/22/2021 4:44:22 PM
Aquestive Therapeutics to Announce Fourth Quarter and Year End 2020 Financial Results and Recent Business Highlights on March... GlobeNewswire Inc. - 2/17/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/9/2021 7:35:36 AM
Aquestive Therapeutics Appoints Mark Lepore, MD, as Chief Medical Officer for Allergy GlobeNewswire Inc. - 1/28/2021 7:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/21/2021 4:34:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/21/2021 8:41:01 AM
Mitsubishi Tanabe Pharma America and Aquestive Therapeutics Announce U.S. Licensing and Supply Deal for Riluzole Oral Film fo... PR Newswire (US) - 1/21/2021 8:30:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 1/20/2021 6:05:35 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 1/8/2021 4:46:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/8/2021 7:01:03 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/7/2021 7:36:05 AM
Aquestive Therapeutics Provides Business Update GlobeNewswire Inc. - 1/7/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 4:06:10 PM
Aquestive Therapeutics to Present at Two Upcoming Investor Conferences GlobeNewswire Inc. - 1/4/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2020 7:00:55 AM
Aquestive Therapeutics Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer GlobeNewswire Inc. - 12/16/2020 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 12/1/2020 6:01:05 AM
Aquestive Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire Inc. - 11/25/2020 9:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2020 7:15:57 AM
Aquestive Therapeutics Receives First Milestone Payment from KYNMOBI™ Monetization GlobeNewswire Inc. - 11/23/2020 7:00:00 AM
Aquestive Therapeutics Completes FDA Type A Meeting on Libervant GlobeNewswire Inc. - 11/18/2020 4:01:00 PM
DorseyE   Tuesday, 06/02/20 11:37:28 PM
Re: Aarin post# 122
Post # of 143 
Upcoming PDUFA 9/27/20
PDUFA 3/02/21

Never posted anything like this but maybe a buyout target with all their potential!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences